Ruilan Wang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Heme Oxygenase-1 and Carbon Monoxide 7
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
- Respiratory Support and Mechanisms 5
- Co-authors
- Xiaoxiao Meng (24 shared papers)Hui Xie (5 shared papers)Jiaxiang Zhang (11 shared papers)Rui Tian (13 shared papers)Yong Zhu (2 shared papers)Jinfeng Wang (2 shared papers)Yong Zhu (9 shared papers)Hui Xie (8 shared papers)
- Journals
- BMC Infectious Diseases (4 papers)Journal of Materials Science Materials in Electronics (3 papers)Annals of Translational Medicine (2 papers)Infection and Drug Resistance (2 papers)Journal of Cellular and Molecular Medicine (2 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Ruilan Wang
93 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 121
- Cancer Research 241
- Critical Care and Intensive Care Medicine 59
- Pulmonary and Respiratory Medicine 360
- Molecular Biology 493
- Immunology 133
Countries citing papers authored by Ruilan Wang
This map shows the geographic impact of Ruilan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruilan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruilan Wang more than expected).
Fields of papers citing papers by Ruilan Wang
This network shows the impact of papers produced by Ruilan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruilan Wang. The network helps show where Ruilan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruilan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 119 | |
| 2 | 2016 | 102 | |
| 3 | 2019 | 85 | |
| 4 | 2021 | 66 | |
| 5 | 2021 | 65 | |
| 6 | 2021 | 63 | |
| 7 | 2019 | 59 | |
| 8 | 2017 | 49 | |
| 9 | 2019 | 45 | |
| 10 | 2017 | 41 | |
| 11 | 2019 | 39 | |
| 12 | 2020 | 37 | |
| 13 | 2021 | 35 | |
| 14 | 2024 | 31 | |
| 15 | 2018 | 31 | |
| 16 | Prediction about severity and outcome of sepsis by pro-atrial natriuretic peptide and pro-adrenomedullin. | 2010 | 30 |
| 17 | 2021 | 28 | |
| 18 | 2017 | 27 | |
| 19 | 2017 | 26 | |
| 20 | 2015 | 25 |
About Ruilan Wang
Ruilan Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Epidemiology and Cancer Research, having authored 99 papers that have together received 1.6k indexed citations. Recurring topics across this work include Heme Oxygenase-1 and Carbon Monoxide (7 papers), Paraquat toxicity studies and treatments (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Cancer, Hypoxia, and Metabolism (6 papers), Sepsis Diagnosis and Treatment (6 papers), Respiratory Support and Mechanisms (5 papers), Antibiotic Resistance in Bacteria (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Cancer Research (241 citations), Critical Care and Intensive Care Medicine (59 citations), Pulmonary and Respiratory Medicine (360 citations), Molecular Biology (493 citations) and Immunology (133 citations). Ruilan Wang has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Xiaoxiao Meng, Hui Xie, Jiaxiang Zhang, Rui Tian, Yong Zhu, Jinfeng Wang, Yong Zhu, Hui Xie, Dapeng Wang and Jian Lü. Their work appears in journals such as BMC Infectious Diseases, Journal of Materials Science Materials in Electronics, Annals of Translational Medicine, Infection and Drug Resistance and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.